These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 22705192)

  • 21. [Voltage-dependent potassium channel and calcium-activated potassium channel current changes of peripheral blood T-lymphocytes from hypertensive patients in Xinjiang Kazakh].
    Zhang QB; Zhang YM; Cheng LF; Yuan QY; Zhang GM; Liang P; Gou F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1020-4. PubMed ID: 24524604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kv1.3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome.
    Xu R; Cao M; Wu X; Wang X; Ruan L; Quan X; Lü C; He W; Zhang C
    Clin Immunol; 2012 Feb; 142(2):209-17. PubMed ID: 22169811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
    Wulff H; Calabresi PA; Allie R; Yun S; Pennington M; Beeton C; Chandy KG
    J Clin Invest; 2003 Jun; 111(11):1703-13. PubMed ID: 12782673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K
    Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
    Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
    Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
    Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns.
    Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
    Oncotarget; 2016 Jul; 7(29):44966-44974. PubMed ID: 27329601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potassium channels as therapeutic targets for autoimmune disorders.
    Wulff H; Beeton C; Chandy KG
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
    Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
    Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders?
    Vianna-Jorge R; Suarez-Kurtz G
    BioDrugs; 2004; 18(5):329-41. PubMed ID: 15377175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis.
    Keystone EC; Poplonski L; Snow KM; Martell M
    Clin Exp Immunol; 1989 Nov; 78(2):184-8. PubMed ID: 12412746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment?
    Wang J; Xiang M
    Pharmacotherapy; 2013 May; 33(5):515-28. PubMed ID: 23649812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
    Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
    J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
    Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
    Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered memory T cell differentiation in patients with early rheumatoid arthritis.
    Skapenko A; Wendler J; Lipsky PE; Kalden JR; Schulze-Koops H
    J Immunol; 1999 Jul; 163(1):491-9. PubMed ID: 10384153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.
    Nicolaou SA; Neumeier L; Takimoto K; Lee SM; Duncan HJ; Kant SK; Mongey AB; Filipovich AH; Conforti L
    Cell Calcium; 2010 Jan; 47(1):19-28. PubMed ID: 19959227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
    Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Th1 and Th2 lymphocytes are distinguished by calcium flux regulation during the first 10 min of lymphocyte activation.
    Toldi G; Kaposi A; Zsembery Á; Treszl A; Tulassay T; Vásárhelyi B
    Immunobiology; 2012 Jan; 217(1):37-43. PubMed ID: 21899918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.